Back to Search Start Over

Central venous catheter-related bloodstream infections: Epidemiology and risk factors for hematogenous complications.

Authors :
Ngo Bell EC
Chapon V
Bessede E
Meriglier E
Issa N
Domblides C
Bonnet F
Vandenhende MA
Source :
Infectious diseases now [Infect Dis Now] 2024 Apr; Vol. 54 (3), pp. 104859. Date of Electronic Publication: 2024 Feb 01.
Publication Year :
2024

Abstract

Background: Central catheter-related bloodstream infections (CRBIs) can lead to severe complications, including suppurative thrombophlebitis, endocarditis, and metastatic infections. While complications due to CRBIs caused by Staphylococcus aureus (SA) are well-known, there are limited data regarding CRBIs caused by other bacteria.<br />Methods: This 2-year retrospective single-center study of patients with CRBIs from a tertiary care hospital examined the hematogenous complications associated with CRBIs according to patient characteristics, central venous catheter (CVC) types, and causative bacteria.<br />Results: All in all, 254 patients with confirmed CRBIs were included; 285 bacteria types were isolated, mainly Enterobacteriaceae (n = 94), coagulase-negative Staphylococci (CNS, n = 82), SA (n = 45), and non-fermenting Gram-negative bacteria (NGB, n = 45). Among the patients, 35 developed at least one hematogenous complication (14 %), including suppurative thrombophlebitis (n = 15), endocarditis (n = 7) and metastatic infections (n = 16). In multivariate analysis, hemodialysis, persistent bacteremia for at least 3 days, and CRBIs caused by SA were associated with increased risk for hematogenous complications, while previous curative anticoagulant treatment was associated with reduced risk. Diabetes, CVC maintenance, and hematogenous complications were associated with increased 3-month mortality.<br />Conclusion: A thorough investigation of hematogenous complications should be envisioned in patients with persistent bacteremia, particularly those with SA infections and those on hemodialysis.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
2666-9919
Volume :
54
Issue :
3
Database :
MEDLINE
Journal :
Infectious diseases now
Publication Type :
Academic Journal
Accession number :
38309647
Full Text :
https://doi.org/10.1016/j.idnow.2024.104859